Infusion of atrial natriuretic factor at 0.3 and 1.0 micrograms/min significantly lowered plasma renin activity and aldosterone, while 1.0 microgram/min significantly lowered systolic blood pressure.
To evaluate the physiological effects of human atrial natriuretic factor-(99-126) (ANF), we infused ANF, 0.1, 0.3, and 1.0 micrograms/min, or placebo for 125 minutes on different days into six sodium-deprived normal men. During the last 45 minutes of infusion, angiotensin II, 6 ng/kg/min, was infused. Blood pressure, heart rate, plasma concentrations of ANF, aldosterone, and cortisol, and plasma renin activity (PRA) were measured before and during infusion. Steady state mean plasma ANF levels during infusion were 26.2 (placebo), 68.8 (0.1 micrograms ANF/min), 221 (0.3 micrograms ANF/min), and 648 pg/ml (1.0 microgram ANF/min). Systolic blood pressure fell significantly (with 1.0 microgram ANF/min), and diastolic pressure tended to rise in a dose-dependent manner, while heart rate was unchanged. PRA and plasma aldosterone fell during ANF infusion in a dose-dependent manner (significant with 0.3 and 1.0 microgram ANF/min infused). The blood pressure-raising and aldosterone-stimulating effects of angiotensin II were blunted by ANF (significant only with 1.0 microgram ANF/min). It is concluded that effects of ANF on blood pressure and the renin-aldosterone system occur with plasma ANF levels close to the physiological range, as well as with slightly elevated ANF levels, as observed in congestive heart failure and renal insufficiency.
Oelkers et al. (Sat,) conducted a other in Healthy volunteers (sodium-deprived) (n=6). Human atrial natriuretic factor-(99-126) (ANF) vs. Placebo was evaluated on Blood pressure, heart rate, plasma concentrations of ANF, aldosterone, cortisol, and plasma renin activity. Infusion of atrial natriuretic factor at 0.3 and 1.0 micrograms/min significantly lowered plasma renin activity and aldosterone, while 1.0 microgram/min significantly lowered systolic blood pressure.